This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2017 Aug 31;377(9):849-861.

doi: 10.1056/NEJMra1703413.

Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer

Martin Reck¹, Klaus F Rabe¹

Affiliations

Affiliation

¹ From LungenClinic Grosshansdorf and Airway Research Center North, Grosshansdorf (M.R., K.F.R.), the German Center for Lung Research, Giessen (M.R., K.F.R.), University of Lübeck, Lübeck (M.R.), and Christian Albrechts University Kiel, Kiel (K.F.R.) - all in Germany.

PMID: 28854088
DOI: 10.1056/NEJMra1703413

Review

Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer

Martin Reck et al. N Engl J Med. 2017.

. 2017 Aug 31;377(9):849-861.

doi: 10.1056/NEJMra1703413.

Authors

Martin Reck¹, Klaus F Rabe¹

Affiliation

¹ From LungenClinic Grosshansdorf and Airway Research Center North, Grosshansdorf (M.R., K.F.R.), the German Center for Lung Research, Giessen (M.R., K.F.R.), University of Lübeck, Lübeck (M.R.), and Christian Albrechts University Kiel, Kiel (K.F.R.) - all in Germany.

PMID: 28854088
DOI: 10.1056/NEJMra1703413

No abstract available

PubMed Disclaimer

Comment in

Advanced Non–Small-Cell Lung Cancer.
Kwon HW, Ham SY, Shin SW. Kwon HW, et al. N Engl J Med. 2017 Nov 16;377(20):1997-8. doi: 10.1056/NEJMc1712794. N Engl J Med. 2017. PMID: 29143517 No abstract available.
Advanced Non–Small-Cell Lung Cancer.
Ren C, Han C, Wang D. Ren C, et al. N Engl J Med. 2017 Nov 16;377(20):1998. doi: 10.1056/NEJMc1712794. N Engl J Med. 2017. PMID: 29143518 No abstract available.
Advanced Non–Small-Cell Lung Cancer.
Sohal SS, Walters EH. Sohal SS, et al. N Engl J Med. 2017 Nov 16;377(20):1998-9. doi: 10.1056/NEJMc1712794. N Engl J Med. 2017. PMID: 29143519 No abstract available.

Similar articles

Endobronchial ultrasonography (EBUS)--its role in staging of non-small cell lung cancer and who should do it?
Andrade RS, Odell DD, D'Cunha J, Maddaus MA. Andrade RS, et al. J Thorac Cardiovasc Surg. 2012 Sep;144(3):S9-13. doi: 10.1016/j.jtcvs.2012.03.068. J Thorac Cardiovasc Surg. 2012. PMID: 22898528 No abstract available.
EGFR mutations in non-small-cell lung cancer.
Hung JJ, Jeng WJ, Hsu WH, Liu JS, Wu YC. Hung JJ, et al. Lancet Oncol. 2010 May;11(5):412-3; author reply 413. doi: 10.1016/S1470-2045(10)70065-6. Lancet Oncol. 2010. PMID: 20434712 No abstract available.
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.
Hanna N, Johnson D, Temin S, Masters G. Hanna N, et al. J Oncol Pract. 2017 Dec;13(12):832-837. doi: 10.1200/JOP.2017.026716. Epub 2017 Aug 29. J Oncol Pract. 2017. PMID: 28850309 No abstract available.
Recent clinical advances in lung cancer management.
Johnson DH, Schiller JH, Bunn PA Jr. Johnson DH, et al. J Clin Oncol. 2014 Apr 1;32(10):973-82. doi: 10.1200/JCO.2013.53.1228. Epub 2014 Feb 24. J Clin Oncol. 2014. PMID: 24567433 Review.
Emerging gene mutation targets in lung cancer.
Johnson BE. Johnson BE. Clin Adv Hematol Oncol. 2015 Dec;13(12):812-4. Clin Adv Hematol Oncol. 2015. PMID: 27058846 Review. No abstract available.

See all similar articles

Cited by

Roburic acid inhibits lung cancer metastasis and triggers autophagy as verified by network pharmacology, molecular docking techniques and experiments.
Wang L, Chen H, Deng L, Hu M, Wang Z, Zhang K, Lian C, Wang X, Zhang J. Wang L, et al. Front Oncol. 2024 Oct 10;14:1449143. doi: 10.3389/fonc.2024.1449143. eCollection 2024. Front Oncol. 2024. PMID: 39450260 Free PMC article.
Preliminary exploration of poor prognostic factor IL-33 and its involvement in perioperative immunotherapy in stage II-III lung squamous cell carcinoma: a retrospective cohort study.
Liu Y, Liu P, Zhang R, Seki N, Forest F, Brueckl WM, Zhao C, Zhang C, Yu J. Liu Y, et al. J Thorac Dis. 2024 Sep 30;16(9):6204-6215. doi: 10.21037/jtd-24-1122. Epub 2024 Sep 18. J Thorac Dis. 2024. PMID: 39444909 Free PMC article.
Establish a novel immune-related gene prognostic risk index (IRGPRI) associated with CD8+ cytotoxic T lymphocytes in non-small-cell lung cancer (NSCLC).
Cui S, Yang Y, Lou S, Huang R, Wang J, Chen Z, Xie J. Cui S, et al. Heliyon. 2024 Sep 24;10(19):e38324. doi: 10.1016/j.heliyon.2024.e38324. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39397989 Free PMC article.
Predictability of Neutrophile to Lymphocyte Ratio and Platelet to Lymphocyte Ratio on the Effectiveness of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer patients: A Meta-Analysis.
Nguyen CTT, Van TNK, Huong PT. Nguyen CTT, et al. Cancer Control. 2024 Jan-Dec;31:10732748241285474. doi: 10.1177/10732748241285474. Cancer Control. 2024. PMID: 39285591 Free PMC article.
Cost-effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR-mutated advanced non-small cell lung cancer.
Tian W, Niu L, Zhou R, Wang Z, Ning J, Lu R, Shi Y, Tan Z. Tian W, et al. Cancer Med. 2024 Aug;13(16):e70083. doi: 10.1002/cam4.70083. Cancer Med. 2024. PMID: 39206619 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information